Method for treating crohn'S disease or ulcerative colitis by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
The present invention relates to the field of therapeutic methods, compositions and uses thereof, that affect, directly or indirectly, the behavior of LRP receptors. These compositions and methods result in the treatment of inflammatory, immunological and metabolic conditions. More particularly, the methods and compositions of the invention are directed to the identification of small molecules, drugs and/or pharmacological agents that affect the Wnt pathway by affecting normal complex formation among various signaling receptors, the LRP5 and LRP6 receptor, and related ligands.
1. A method for treating Crohn's disease or ulcerative colitis, comprising:
administering to a human patient having Crohn's disease or ulcerative colitis a therapeutically effective amount of a compound selected from the group consisting of:
2. The method of claim 1 , wherein the human patient has Crohn's disease.
3. The method of claim 1 , wherein the human patient has ulcerative colitis.
4. The method of claim 2 , wherein the compound is
5. The method of claim 2 , wherein the compound is
6. The method of claim 2 , wherein the compound is
7. The method of claim 3 , wherein the compound is
8. The method of claim 3 , wherein the compound is
9. The method of claim 3 , Wherein the compound is